Authors: Evans, PC Smith, S Hirschfield, G Rigopoulou, E Wreghitt, TG Wight, DGD Taylor, CJ Alexander, GJM

Citation: Pc. Evans et al., Recipient HLA-DR3, tumour necrosis factor-alpha promoter allele-2 (tumour necrosis factor-2) and cytomegalovirus infection are interrelated risk factors for chronic rejection of liver grafts, J HEPATOL, 34(5), 2001, pp. 711-715

Authors: Walsh, KM Woodall, T Lamy, P Wight, DGD Bloor, S Alexander, GJM

Citation: Km. Walsh et al., Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus, GUT, 49(3), 2001, pp. 436-440

Authors: Lachmann, RH Wight, DGD Lomas, DJ Fisher, NC Schofield, JP Elias, E Cox, TM

Citation: Rh. Lachmann et al., Massive hepatic fibrosis in Gaucher's disease: Clinicopathological and radiological features, QJM-MON J A, 93(4), 2000, pp. 237-244

Authors: Evans, PC Soin, A Wreghitt, TG Taylor, CJ Wight, DGD Alexander, GJM

Citation: Pc. Evans et al., An association between cytomegalovirus infection and chronic rejection after liver transplantation, TRANSPLANT, 69(1), 2000, pp. 30-35

Authors: Evans, PC Coleman, N Wreghitt, TG Wight, DGD Alexander, GJM

Citation: Pc. Evans et al., Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts, J HEPATOL, 31(5), 1999, pp. 913-920

Authors: Mahadeva, R Chang, WSW Dafforn, TR Oakley, DJ Foreman, RC Calvin, J Wight, DGD Lomas, DA

Citation: R. Mahadeva et al., Heteropolymerization of S, I, and Z alpha(1)-antitrypsin and liver cirrhosis, J CLIN INV, 103(7), 1999, pp. 999-1006